Intended for healthcare professionals

Rapid response to:

Editor's Choice

Turning the tide on conflicts of interest

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d5147 (Published 10 August 2011) Cite this as: BMJ 2011;343:d5147

Rapid Response:

Re:Time to curtail the excesses of vested interest

[Edited by Sharon Davies on 25 August 2011 on legal advice]

I refer to a BMJ Group press release published on the Wall Street
Journal website last week 'BMJ Group Chooses SDL to Support Medical
Translations for Univadis Online Platform'[1]. Anyone reading either the
title or indeed the entire text of the release might suppose that
'Univadis' was a BMJ product rather than the information arm of
pharmaceutical manufacturer MSD (Merck Sharp & Dohme).[2]

When Dr Godlee was challenged about this in March she explained that
this and other conflicts on the part of BMJ editorial staff had not been disclosed in an editorial and two ‘editors’ choices' that accompanied Mr Brian
Deer's allegations against Andrew Wakefield over MMR because "it did not
occur to us to do so" [3]. Well, surely it must have done now.

[1] 'BMJ Group Chooses SDL to Support Medical Translations for
Univadis Online Platform'

http://www.marketwatch.com/story/bmj-group-chooses-sdl-to-support-medica...

[2] http://www.univadis.co.uk/medical_and_more/en_GB_Login

[3] Fiona Godlee 'In response to John Stone'
http://www.bmj.com/content/342/bmj.d1335.extract/reply#bmj_el_251470

Competing interests: Autistic son

23 August 2011
Stone
UK Editor
Age of Autism